Literature DB >> 8379959

Autoinhibition of murine macrophage-mediated oxidation of low-density lipoprotein by nitric oxide synthesis.

W Jessup1, R T Dean.   

Abstract

Murine peritoneal macrophages treated with gamma-interferon and lipopolysaccharide (activated cells) oxidized low-density lipoprotein (LDL) less readily than unstimulated cells. Activated cells expressed the enzyme nitric oxide synthase, whose activity was measured by the accumulation of nitrite in the culture supernatant. Treatment of activated macrophages with the arginine analogue NG-monomethyl-arginine (NMMA) inhibited nitric oxide synthesis and restored the ability of the cells to oxidize LDL. This treatment had no effect on the ability of unstimulated cells to oxidize LDL. Similarly, LDL oxidation by activated macrophages in arginine-free Ham's F-10 medium was identical to that of unstimulated cells, whereas restoration of arginine to the medium was associated with nitrite secretion and a decline in LDL oxidation by activated cells only. An inverse relationship between nitric oxide synthesis and LDL oxidation was also demonstrated in the presence of diphenylene iodonium, a flavin analogue which is a potent inhibitor of nitric oxide synthase. Thus nitric oxide synthesis appears to mediate the suppression of LDL oxidation which is associated with the activation of mouse macrophages by gamma-interferon and lipopolysaccharide.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8379959     DOI: 10.1016/0021-9150(93)90111-7

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  4 in total

1.  Inhibition by interferon-gamma of human mononuclear cell-mediated low density lipoprotein oxidation. Participation of tryptophan metabolism along the kynurenine pathway.

Authors:  S Christen; S R Thomas; B Garner; R Stocker
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

2.  Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.

Authors:  H O Steinberg; H Chaker; R Leaming; A Johnson; G Brechtel; A D Baron
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

3.  Nitric oxide function in atherosclerosis.

Authors:  K E Matthys; H Bult
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

4.  Modulation of nitric oxide synthase activity in macrophages.

Authors:  P G Jorens; K E Matthys; H Bult
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.